GlassScriptPhysician profile
Jeanne H Thurber
NPI 1144351768
$2,752.60
in general payments reported to CMS, 2019-2025
12 companies · $663 in 2025
The $663 reported for 2025 was more than what 84% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,315 · 2020: $269 · 2022: $11.86 · 2023: $95.41 · 2024: $399 · 2025: $663.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,157.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $1,131.36 | 2019 | |
| Coopervision INC. | $423.42 | 2019-2025 | Myday Contact Lens, Misight Contact Lens |
| Bausch & Lomb Americas INC. | $315.48 | 2023-2025 | Infuse |
| Alcon Vision LLC | $230.83 | 2024-2025 | Tryptyr |
| Topcon Healthcare, INC. | $174.90 | 2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $128.07 | 2020 | |
| Sun Pharmaceutical Industries INC. | $123.43 | 2020 | |
| Glaukos Corporation | $74.13 | 2024 | Radius |
| Dompe US, INC. | $71.91 | 2025 | Oxervate |
| Allergan, INC. | $49.97 | 2019 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Abbvie INC. | $11.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeanne Thurber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.